Amylyx Pharmaceuticals, Inc. (AMLX) Misses Q4 Earnings Estimates
Amylyx(AMLX) Zacks Investment Research·2024-02-22 22:15财务表现 - Amylyx Pharmaceuticals, Inc. (AMLX)第四季度每股收益为0.07美元，低于Zacks Consensus Estimate的0.20美元[1] - Amylyx Pharmaceuticals, Inc.第四季度营收为1.0845亿美元，超过Zacks Consensus Estimate 1.93%[3] - Amylyx Pharmaceuticals, Inc.股价自年初以来上涨约4%，略低于标普500指数的涨幅[6]